University of Malaya

um.edu.my

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

270

Active

42

Phase 3

10

Total enrollment

33,845

Pipeline matrix

Showing 21 of 21 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Palonosetron—————2
Parestat—————1
Dynastat—————1
Ropivacaine + saline solution—————1
Ropivacaine + Dexmedetomidine—————1
Granisetron—————1
38% Silver Fluoride—————1
Pembrolizumab—————2
Cisplatin—————1
Carboplatin—————1
Gemcitabine—————1
Gengigel—————1
Normal saline————6
Morphine————2
Ketamine-Morphine PCA—————1
Opioid Analgesic—————1
Dexametasone—————1
Water for—————1
Dexmedetomidine—————1
Topical Maternal Breast Milk—————1
Commercial Barrier Cream—————1

Next readouts

  • 2025-08-12
  • 2025-12
  • 2025-12-01
  • 2026-07-31
  • 2026-08-30
  • 2026-08-31
  • 2026-12
  • 2026-12
  • 2027-07-01
  • 2027-07-22

Top conditions

  • Critical Illness6
  • Periodontitis6
  • Depression5
  • Postoperative Pain5
  • Orthodontic Appliance Complication5
  • Quality of Life4
  • Stroke4
  • Dental Anxiety4

Frequently asked questions about University of Malaya

How many clinical trials does University of Malaya have on ClinicalTrials.gov?
University of Malaya is listed as the lead sponsor on 270 clinical trials in ClinicalTrials.gov, 42 of which are currently active (recruiting, enrolling, or ongoing).
How many of University of Malaya's trials are in Phase 3?
10 of University of Malaya's trials are in Phase 3, spread across 21 active drug programs.
What therapeutic areas does University of Malaya focus on?
University of Malaya's most-studied conditions on ClinicalTrials.gov are Critical Illness, Periodontitis, Depression, Postoperative Pain, Orthodontic Appliance Complication.
When are University of Malaya's next clinical trial readouts?
University of Malaya has 10 upcoming primary-completion readouts tracked here; the soonest is “Pilot Study of Throat Packs Soaked in Gengigel Spray in Patients Undergoing Elective Surgery”, expected around 2025-08-12.